Latest medical news · page 78
The latest headlines across every section, pulled from official and open-access sources.
Make the most out of FMX
Federal government shutdown: What family physicians need to know—and do
Episode 238 -- September 2025 -- Part 2 AFP: American Family Physician
Lymphadenopathy (1:30), galantamine for dementia (5:30), parenteral agents for migraines (7:30), EpiSwitch prostate cancer screening test (10:40), vitamin B12 deficiency (14:00), and fezolinetant for menopause (17:40).
FDA expands Tremfya (guselkumab) approval
Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech
FDA expands Tremfya (guselkumab) approval
Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech
FDA expands Tremfya (guselkumab) approval
Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech
FDA approves Keytruda Qlex (pembrolizumab, berahyaluronidase alfa-pmph)
Original biologic license approval. injectable, injection. Sponsor: Merck Sharp Dohme
FDA approves Keytruda Qlex (pembrolizumab, berahyaluronidase alfa-pmph)
Original biologic license approval. injectable, injection. Sponsor: Merck Sharp Dohme
Level 1 - Oropouche in the Americas
Areas in several countries are reporting a low number of cases of Oropouche. Oropouche is spread primarily through the bites of infected midges (small flies) and mosquitoes. Country List : Brazil, Peru, Cuba, Panama
Episode 66 - Diamantis Plachouras - The Silent Spread - Europe’s C. auris Challenge
In this episode of ECDC On Air , we talk to ECDC's Head of Section - Antimicrobial Resistance and Healthcare-Associated Infections - Dr Diamantis Plachouras , who explains the rising threat of the drug-resistant fungus Candidozyma (Candida) auris . Discovered only in 2009, C. auris has become a serious problem in European hospitals - spreading between patients, persisting on surfaces and equipment, and resisting multiple antifungal treatments. Diamantis outlines how infections develop, why treatment is so difficult, and what the latest ECDC survey shows: over 4,000 EU/EEA cases since 2013…
Episode 237 -- September 2025 -- Part 1 AFP: American Family Physician
Respiratory syncytial virus vaccination in pregnancy (1:30), vasectomy (3:40), donanemab in Alzheimer disease (7:20), multicancer early detection (12:20), autism spectrum disorder (13:50), and acute pancreatitis (17:10).
What You May Have Missed in 2024: Part 1
Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."
AAFP urges withdrawal of proposed PSLF rule
Episode 65 - All you Need to Know about Traineeships at ECDC
In this episode of ECDC On Air, trainees from the European Centre for Disease Prevention and Control share their unique experiences and insights about the traineeship program. They discuss their backgrounds, daily responsibilities, and provide valuable advice for future trainees. The conversation also covers life in Stockholm, career opportunities post-traineeship, and answers to audience questions, culminating in a rapid-fire round of fun questions. So, meet Arnau Cabruja Amat, Paula Messa Carmona, Dana Alsaialy and Márcia Luís - and find out more about the traineeships at ECDC. Interested in…
FDA expands Koselugo (selumetinib sulfate) approval
Efficacy supplement (new or revised indication). capsule, oral. Sponsor: Astrazeneca
FDA approves Koselugo (selumetinib)
Original new drug approval. capsule, oral. Sponsor: Astrazeneca
NIH releases Alzheimer’s Disease and Related Dementias Research Progress Report and FY27 Professional Judgment Budget
NIH released the FY 2027 Professional Judgment Budget for Alzheimer’s Disease and Related Dementias and the NIH Scientific Progress Report.
FDA expands Skyrizi (risankizumab-rzaa) approval
Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Abbvie Inc
FDA expands Skyrizi (risankizumab-rzaa) approval
Efficacy supplement (new or revised indication). injectable, intravenous. Sponsor: Abbvie Inc
Level 2 - Yellow Fever in Colombia
An increased number of cases of yellow fever have been reported in Colombia.
Fibrillation - When Ablation is the Way to Go
Dr. Centor discusses the role of ablation in the management of patients with atrial fibrillation with Dr. Peter Zimetbaum.
Episode 236 -- August 2025 -- Part 2 AFP: American Family Physician
Contraception (1:30), delayed pushing in labor (6:10), bacterial vaginosis (8:50), outpatient care of the premature infant (11:10), nocturnal leg cramps (17:30), and AFP Clinical Answers (19:20).
Episode 235 - August 2025 - Part 1 AFP: American Family Physician
Heart failure with reduced ejection fraction (1:30), lower gastrointestinal bleeding (5:10), venous leg ulcers (7:10), nonopioid pharmacologic management of chronic pain (10:30), resuscitation in burns (15:20), and breast ductal carcinoma in situ (17:10).